• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy
    Subscribe to $QIPT

    Quipt Home Medical Corp.

    Subscribe to $QIPT
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    Quipt Home Medical Corp. provides in-home monitoring equipment and disease management services includes end-to-end respiratory solutions for patients in the United States. It offers daily and ambulatory aides; power mobility equipment; BiPAP and CPAP machines, nebulizers, oxygen concentrators, and ventilators; oxygen therapy; sleep apnea and PAP treatment equipment; and home ventilator equipment, as well as rents respiratory equipment. The company also offers management of various chronic disease states focusing on patients with heart and pulmonary disease, sleep disorders, reduced mobility, and other chronic health conditions. The company was formerly known as Protech Home Medical Corp. and changed its name to Quipt Home Medical Corp. in May 2021. Quipt Home Medical Corp. was incorporated in 1993 and is headquartered in Wilder, Kentucky.

    IPO Year:

    Exchange: NASDAQ

    Website: quipthomemedical.com

    Recent Analyst Ratings for Quipt Home Medical Corp.

    DatePrice TargetRatingAnalyst
    5/14/2025$1.70Buy → Hold
    Canaccord Genuity
    5/17/2024Mkt Perform → Underperform
    Raymond James
    2/16/2024Outperform → Mkt Perform
    Raymond James
    6/14/2023$11.00Buy
    Canaccord Genuity
    10/20/2021$7.50Buy
    The Benchmark Company
    10/20/2021$7.50Buy
    Benchmark
    See more ratings

    Quipt Home Medical Corp. Press Releases

    Fastest customizable press release news feed in the world

    View All

    Quipt Home Medical Completes the Previously Announced Arrangement With Affiliates of Kingswood and Forager

    CINCINNATI, March 16, 2026 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (the "Company" or "Quipt") (NASDAQ:QIPT, TSX:QIPT)‎, a U.S. based home medical equipment provider, focused on end-to-end respiratory care, is pleased to announce the successful completion of the previously-announced plan of arrangement under the provisions of the Business Corporations Act (British Columbia) (the "Arrangement") in accordance with an arrangement agreement (the "Arrangement Agreement") dated December 14, 2025 among the Company, 1567208 B.C. Ltd. (the "Purchaser") and REM Aggregator, LLC. Pursuant to the Arrangement, and in accordance with the terms of the Arrangement Agreement, the Purchaser, which inclu

    3/16/26 7:30:00 AM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    Quipt Home Medical Receives Final Order Approving Arrangement

    CINCINNATI, March 05, 2026 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (the "Company") (NASDAQ:QIPT, TSX:QIPT)‎, a U.S. based home medical equipment provider, focused on end-to-end respiratory care, announces that the Supreme Court of British Columbia issued a final order today in connection with the previously announced plan of arrangement under the Business Corporations Act (British Columbia) (the "Arrangement") pursuant to which affiliates of Kingswood Capital Management, L.P. and Forager Capital Management, LLC will acquire all of the issued and outstanding common shares of the Company (each, a "Share") for cash consideration of US$3.65 per Share. The final order was the final substan

    3/5/26 8:30:00 PM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    Quipt Home Medical Announces Voting Results From Special Meeting of Shareholders

    CINCINNATI, March 03, 2026 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (the "Company") (NASDAQ:QIPT, TSX:QIPT)‎, a U.S. based home medical equipment provider, focused on end-to-end respiratory care, today announced the voting results from its special meeting of holders (the "Shareholders") of common shares (the "Shares") of the Company held on March 3, 2026 (the "Meeting") in Sarasota, Florida. The Shareholders voted to approve the special resolution (the "Arrangement Resolution") approving the plan of arrangement under the Business Corporations Act (British Columbia), involving, among other things, the acquisition by affiliates of Kingswood Capital Management, L.P. and Forager Capital Ma

    3/3/26 5:00:00 PM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    Quipt Home Medical Corp. Announces Filing and Mailing of Proxy Statement and Information Circular and Receipt of Interim Order in Connection With Plan of Arrangement

    CINCINNATI, Feb. 04, 2026 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. ("Quipt" or the "Company") (NASDAQ:QIPT, TSX:QIPT), a U.S. based home medical equipment provider, focused on end-to-end respiratory care, is pleased to announce the filing of its definitive proxy statement and management information circular (the "Circular") in connection with Quipt's upcoming special meeting (the "Meeting") of the holders (the "Shareholders") of Quipt's common shares (the "Shares") to be held on March 3, 2026, at 10:00 a.m. (Eastern Standard Time). The Circular is available under Quipt's profile on SEDAR+ at www.sedarplus.com, with the U.S. Securities and Exchange Commission (the "SEC") on the EDGAR we

    2/4/26 5:00:00 PM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    Quipt Home Medical Enters Into Definitive Agreement for Its Acquisition by Affiliates of Kingswood Capital Management and Forager Capital Management

    Quipt shareholders to receive US$3.65 per share in cashTransaction provides immediate liquidity and certainty of value to shareholdersThe per share purchase price represents a 162% premium to Quipt's unaffected stock price on May 19, 2025, the last full trading day prior to the public disclosure of Forager's $3.10 per share proposal, and a 54% premium to Quipt's 30-day VWAP as of December 12, 2025 CINCINNATI, Dec. 15, 2025 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. ("Quipt" or the "Company") (NASDAQ:QIPT, TSX:QIPT), a U.S. based home medical equipment provider, focused on end-to-end respiratory care, today announced that it has entered into a definitive agreement (the "Arrangement Agree

    12/15/25 7:30:00 AM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    Quipt Home Medical Reports Fourth Quarter and Fiscal Year 2025 Financial Results

    CINCINNATI, Dec. 15, 2025 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (the "Company") (NASDAQ:QIPT, TSX:QIPT), a U.S.-based home medical equipment provider focused on end-to-end respiratory care, today announced its fourth quarter and fiscal year 2025 financial results and operational highlights. These results pertain to the three months and year ended September 30, 2025 and are reported in U.S. Dollars under GAAP. Financial Highlights: Revenue for Q4 2025 was $68.3 million compared to $61.3 million for Q4 2024, representing an 11% increase. Sequential organic revenue growth from Q3 2025 was strong at 5%.Recurring Revenue1 for Q4 2025 was strong at 80% of total revenue, driven by the gr

    12/15/25 7:30:00 AM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    Concerned Shareholder Bradley L. Radoff Urges Quipt Home Medical's Board of Directors to Pursue a Value-Maximizing Sale

    Questions Independent Director Mark Greenberg for His Role in Supporting Substantial Dilution of Shareholders and Rebuffing Inbound Interest Intends to Vote Against Every Incumbent Director at 2026 Annual Meeting if the Board Continues to Put Shareholder Value at Risk Bradley L. Radoff, who collectively with his affiliates owns approximately 4.9% of the outstanding common shares of Quipt Home Medical Corp. (NYSE:QIPT) ("Quipt" or the "Company"), today issued the following statement regarding the manner in which the Company's Board of Directors (the "Board") has failed to capitalize on apparent acquirer interest: "The Board has spent years destroying its credibility by presiding over poor

    12/5/25 4:00:00 PM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    Lakeview Urges Quipt's Board to Initiate a Legitimate Review of All Strategic Options Including a Sale, Inclusive of a Credible Bidder's $3.10 All-Cash Offer

    Board Should Run a Real Review Process That is Focused on Building – Not Chilling – Acquirer Interest Lakeview Opportunity Fund, LLC (together with its affiliates, "we" or "Lakeview Investment Group"), a nearly 5% owner, and top 5 shareholder of Quipt Home Medical Corp. ("Quipt" or the "Company") (NASDAQ:QIPT, TSX:QIPT), today expressed its belief that the Company's Board of Directors (the "Board") has undermined the best interests of shareholders by failing to engage in good faith with a credible bidder as part of a transparent and viable strategic review. Rather than open a constructive dialogue with a real bidder and start exploring all avenues to maximize value, the Board has put shar

    10/22/25 12:10:00 PM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    Forager's 120% Premium for Quipt Would Set M&A Benchmark; Board's Inaction Erodes Shareholder IRR

    BIRMINGHAM, Ala., Sept. 10, 2025 (GLOBE NEWSWIRE) -- Forager Capital Management ("Forager"), one of the largest shareholders of Quipt Home Medical Corp. ("Quipt") (NASDAQ:QIPT, TSX:QIPT), with beneficial ownership of 9.7% of the outstanding shares, issued the following statement: "On May 17, 2025 — nearly sixteen weeks ago — Forager submitted an offer to acquire Quipt for $3.10 per share in cash (the "May Offer"). Had Quipt's Board constructively engaged, the transaction could have been completed by now under the timeline outlined in the May Offer. Shareholders would have locked in a 120% return in under six months — a gain that could have already been redeployed into new opport

    9/10/25 8:30:00 AM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    Forager Sets the Record Straight on Recent Efforts to Acquire Quipt for an All-Cash Premium

    Quipt's Convenient Omissions and Lawsuit Demonstrate the Board is Motivated by Self-Serving Tactics Rather than Shareholders' Best Interests Reiterates Commitment to $3.10 Offer and Willingness to Improve Offer Upon Constructive Engagement BIRMINGHAM, Ala., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Forager Capital Management ("Forager"), one of the largest shareholders of Quipt Home Medical Corp. ("Quipt") (NASDAQ:QIPT, TSX:QIPT), with beneficial ownership of 9.7%, today provided the missing context from Quipt's August 27, 2025 public statements: "As long-term shareholders, our motive is simple: to ensure Quipt completes a transaction at the highest possible price and to prevent the Boar

    9/3/25 8:30:00 AM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    Quipt Home Medical Corp. Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Exec VP Operations Gamble Patrick Dennis bought $41,634 worth of shares (17,000 units at $2.45), increasing direct ownership by 74% to 40,057 units (SEC Form 4)

    4 - Quipt Home Medical Corp. (0001540013) (Issuer)

    12/30/24 4:05:11 PM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    Quipt Home Medical Corp. SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13D/A filed by Quipt Home Medical Corp.

    SCHEDULE 13D/A - Quipt Home Medical Corp. (0001540013) (Subject)

    3/16/26 1:46:50 PM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    SEC Form S-8 POS filed by Quipt Home Medical Corp.

    S-8 POS - Quipt Home Medical Corp. (0001540013) (Filer)

    3/16/26 9:27:04 AM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    SEC Form S-8 POS filed by Quipt Home Medical Corp.

    S-8 POS - Quipt Home Medical Corp. (0001540013) (Filer)

    3/16/26 9:26:27 AM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    SEC Form F-10POS filed by Quipt Home Medical Corp.

    F-10POS - Quipt Home Medical Corp. (0001540013) (Filer)

    3/16/26 9:24:37 AM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    SEC Form 25-NSE filed by Quipt Home Medical Corp.

    25-NSE - Quipt Home Medical Corp. (0001540013) (Subject)

    3/16/26 8:31:56 AM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    Quipt Home Medical Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control of Registrant, Leadership Update, Other Events, Financial Statements and Exhibits

    8-K - Quipt Home Medical Corp. (0001540013) (Filer)

    3/16/26 7:41:06 AM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    Quipt Home Medical Corp. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - Quipt Home Medical Corp. (0001540013) (Filer)

    3/5/26 9:14:37 PM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    Quipt Home Medical Corp. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits

    8-K - Quipt Home Medical Corp. (0001540013) (Filer)

    3/3/26 5:06:03 PM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    SEC Form 10-Q filed by Quipt Home Medical Corp.

    10-Q - Quipt Home Medical Corp. (0001540013) (Filer)

    2/9/26 4:06:03 PM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    SEC Form DEFA14A filed by Quipt Home Medical Corp.

    DEFA14A - Quipt Home Medical Corp. (0001540013) (Filer)

    2/4/26 5:07:02 PM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    Quipt Home Medical Corp. Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Quipt Home Medical Corp. Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Quipt Home Medical downgraded by Canaccord Genuity with a new price target

    Canaccord Genuity downgraded Quipt Home Medical from Buy to Hold and set a new price target of $1.70

    5/14/25 8:58:24 AM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    Quipt Home Medical downgraded by Raymond James

    Raymond James downgraded Quipt Home Medical from Mkt Perform to Underperform

    5/17/24 7:45:25 AM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    Quipt Home Medical downgraded by Raymond James

    Raymond James downgraded Quipt Home Medical from Outperform to Mkt Perform

    2/16/24 8:29:00 AM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    Canaccord Genuity resumed coverage on Quipt Home Medical with a new price target

    Canaccord Genuity resumed coverage of Quipt Home Medical with a rating of Buy and set a new price target of $11.00

    6/14/23 8:58:25 AM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    The Benchmark Company initiated coverage on Quipt Home Medical with a new price target

    The Benchmark Company initiated coverage of Quipt Home Medical with a rating of Buy and set a new price target of $7.50

    10/20/21 7:47:04 AM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    Benchmark initiated coverage on Quipt Home Medical with a new price target

    Benchmark initiated coverage of Quipt Home Medical with a rating of Buy and set a new price target of $7.50

    10/20/21 7:12:37 AM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    Director Wessel Brian Joseph returned $787,411 worth of shares to the company (215,729 units at $3.65), closing all direct ownership in the company (SEC Form 4)

    4 - Quipt Home Medical Corp. (0001540013) (Issuer)

    3/16/26 9:46:40 AM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    Chief Accounting Officer Roehrig Thomas returned $631,450 worth of shares to the company (173,000 units at $3.65), closing all direct ownership in the company (SEC Form 4)

    4 - Quipt Home Medical Corp. (0001540013) (Issuer)

    3/16/26 9:45:41 AM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    Chief Compliance Officer Miles Mark Alan returned $401,500 worth of shares to the company (110,000 units at $3.65), closing all direct ownership in the company (SEC Form 4)

    4 - Quipt Home Medical Corp. (0001540013) (Issuer)

    3/16/26 9:45:08 AM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    Director Greenberg Mark Alan returned $1,589,418 worth of shares to the company (435,457 units at $3.65), closing all direct ownership in the company (SEC Form 4)

    4 - Quipt Home Medical Corp. (0001540013) (Issuer)

    3/16/26 9:44:26 AM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    Exec. VP Operations Gamble Patrick Dennis returned $219,208 worth of shares to the company (60,057 units at $3.65), closing all direct ownership in the company (SEC Form 4)

    4 - Quipt Home Medical Corp. (0001540013) (Issuer)

    3/16/26 9:43:32 AM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    President/CEO Crawford Gregory John returned $16,755,427 worth of shares to the company (4,590,528 units at $3.65), closing all direct ownership in the company (SEC Form 4)

    4 - Quipt Home Medical Corp. (0001540013) (Issuer)

    3/16/26 9:43:14 AM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    Director Carter Kevin A. returned $734,234 worth of shares to the company (201,160 units at $3.65), closing all direct ownership in the company (SEC Form 4)

    4 - Quipt Home Medical Corp. (0001540013) (Issuer)

    3/16/26 9:39:55 AM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    Exec. VP Operations Bachelder David returned $80,869 worth of shares to the company (22,156 units at $3.65), closing all direct ownership in the company (SEC Form 4)

    4 - Quipt Home Medical Corp. (0001540013) (Issuer)

    3/16/26 9:39:07 AM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    Chief Financial Officer Mehta Hardik returned $4,564,946 worth of shares to the company (1,250,670 units at $3.65), closing all direct ownership in the company (SEC Form 4)

    4 - Quipt Home Medical Corp. (0001540013) (Issuer)

    3/16/26 9:37:53 AM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    President/CEO Crawford Gregory John exercised 583,500 shares at a strike of $1.11, increasing direct ownership by 21% to 3,351,196 units (SEC Form 4)

    4 - Quipt Home Medical Corp. (0001540013) (Issuer)

    12/15/25 7:26:34 PM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    Quipt Home Medical Corp. Leadership Updates

    Live Leadership Updates

    View All

    Quipt Home Medical Unveils Strategic Priorities for 2025 to Enhance Shareholder Value and Announces Voting Results from its Annual General Meeting

    CINCINNATI, March 24, 2025 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. ("Quipt" or the "Company") (NASDAQ:QIPT, TSX:QIPT)‎, a U.S. based home medical equipment provider, focused on end-to-end respiratory care, is pleased to announce its strategic priorities for calendar 2025 and the voting results from its annual general meeting of shareholders held on March 17, 2025 (the "Meeting") in Sarasota, Florida. The total number of shares represented in person or by proxy at the Meeting was 31,400,043, representing 72.87% of the total issued and outstanding shares in the capital of the Company. As it relates to its strategic priorities for 2025, the Company remains committed to returning to hist

    3/24/25 7:30:00 AM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    Quipt Home Medical Announces Voting Results from Its Annual General and Special Meeting of Shareholders

    CINCINNATI, March 28, 2024 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (the "Company") (NASDAQ:QIPT) (TSX:QIPT)‎, a U.S. based home medical equipment provider, focused on end-to-end respiratory care, today announced the voting results from its annual general and special meeting of shareholders held on March 27, 2024 (the "Meeting") in Wilder, Kentucky. The total number of shares represented in person or by proxy at the Meeting was 25,432,699, representing 60.4% of the total issued and outstanding shares in the capital of the Company. Election of Directors The four candidates nominated for election to the Company's Board of Directors (the "Board") and listed in the Company's manageme

    3/28/24 7:30:00 AM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    Quipt Home Medical Announces New Independent Board Member

    CINCINNATI, Feb. 03, 2022 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. ("Quipt" or the "Company") (NASDAQ:QIPT, TSXV:QIPT), a U.S. based leader in the home medical equipment industry, focused on end-to-end respiratory care, announced today that Mr. Brian J. Wessel has joined the Board of Directors of the Company as an Independent Director and Chair of the Audit Committee. Mr. Wessel is a senior business executive with over 34 years of global client service, operational and financial expertise. As a former senior partner at Ernst & Young ("EY"), Mr. Wessel provided audit and advisory services to public, private, and private-equity-owned companies across multiple industry sectors. Additio

    2/3/22 7:30:00 AM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    Quipt Home Medical Corp. Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Quipt Home Medical Corp. Financials

    Live finance-specific insights

    View All

    SEC Form SC 13D filed by Quipt Home Medical Corp.

    SC 13D - Quipt Home Medical Corp. (0001540013) (Subject)

    12/11/24 4:07:36 PM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    Amendment: SEC Form SC 13G/A filed by Quipt Home Medical Corp.

    SC 13G/A - Quipt Home Medical Corp. (0001540013) (Subject)

    12/11/24 4:06:42 PM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    SEC Form SC 13G filed by Quipt Home Medical Corp.

    SC 13G - Quipt Home Medical Corp. (0001540013) (Subject)

    12/11/24 4:06:09 PM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    SEC Form SC 13G/A filed by Quipt Home Medical Corp. (Amendment)

    SC 13G/A - Quipt Home Medical Corp. (0001540013) (Subject)

    2/7/24 5:09:03 PM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    SEC Form SC 13G filed by Quipt Home Medical Corp.

    SC 13G - Quipt Home Medical Corp. (0001540013) (Subject)

    2/2/24 3:57:30 PM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    SEC Form SC 13G/A filed by Quipt Home Medical Corp. (Amendment)

    SC 13G/A - Quipt Home Medical Corp. (0001540013) (Subject)

    2/6/23 11:39:29 AM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    SEC Form SC 13G filed by Quipt Home Medical Corp.

    SC 13G - Quipt Home Medical Corp. (0001540013) (Subject)

    1/20/22 9:27:59 AM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    Quipt Home Medical Enters Into Definitive Agreement for Its Acquisition by Affiliates of Kingswood Capital Management and Forager Capital Management

    Quipt shareholders to receive US$3.65 per share in cashTransaction provides immediate liquidity and certainty of value to shareholdersThe per share purchase price represents a 162% premium to Quipt's unaffected stock price on May 19, 2025, the last full trading day prior to the public disclosure of Forager's $3.10 per share proposal, and a 54% premium to Quipt's 30-day VWAP as of December 12, 2025 CINCINNATI, Dec. 15, 2025 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. ("Quipt" or the "Company") (NASDAQ:QIPT, TSX:QIPT), a U.S. based home medical equipment provider, focused on end-to-end respiratory care, today announced that it has entered into a definitive agreement (the "Arrangement Agree

    12/15/25 7:30:00 AM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    Quipt Home Medical Reports Improved Fiscal Third Quarter 2025 Results

    Posts Positive Organic Growth and Adjusted EBITDA‎1 of 23.5% of Revenue CINCINNATI, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. ("Quipt" or the "Company") (NASDAQ:QIPT, TSX:QIPT), a U.S. based home medical equipment provider, focused on end-to-end respiratory care, today announced its fiscal third quarter 2025 financial results and operational highlights. These results pertain to the three and nine months ended June 30, 2025, and are reported in United States dollars. Conference Call Quipt will host its Earnings Conference Call on Tuesday, August 12, 2025 at 10:00 a.m. (ET). Interested parties may participate in the call by dialing 1 (833) 752-3722 or 1 (647) 846-85

    8/11/25 5:00:00 PM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    Quipt Home Medical Corp. to Announce Fiscal Third Quarter 2025 Financial Results on August 11, 2025

    CINCINNATI, July 29, 2025 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (the "Company") (NASDAQ:QIPT) (TSX:QIPT), a U.S. based home medical equipment provider, focused on end-to-end respiratory care, will announce its fiscal Third quarter 2025 financial results on Monday, August 11, 2025, after market close. Gregory Crawford, Chief Executive Officer, and Hardik Mehta, Chief Financial Officer, will host a conference call for the investment community on Tuesday, August 12, 2025, at 10:00 a.m. (ET). The call-in numbers for participants are:  Canada/US Toll Free:1 (833) 752 3722 International:1 (647) 846 8549    A live webcast of the call will be accessible via the investor

    7/29/25 7:30:00 AM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    Quipt Home Medical Acquires Healthcare System Owned Medical Equipment Provider with $6.6 Million in Revenue, and Signs Preferred Provider Agreement Covering 20 Hospitals Across 4 States

    CINCINNATI, July 07, 2025 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. ("Quipt" or the "Company") (NASDAQ:QIPT, TSX:QIPT), a U.S. based home medical equipment provider, focused on end-to-end respiratory care, today announced it has acquired a full-service durable medical equipment ("DME") provider, which is wholly owned by Ballad Health (the "Acquiree"). Ballad Health is a prominent integrated health system comprised of 20 hospitals, post-acute care and behavioral health services, and a large multi-specialty group physician practice. Ballad Health serves 29 counties of the Appalachian Highlands in Northeast Tennessee, Southwest Virginia, Northwest North Carolina and Southeast Kentucky. The

    7/7/25 7:30:00 AM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    Quipt Home Medical Reports Fiscal Second Quarter 2025 Results

    CINCINNATI, May 12, 2025 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. ("Quipt" or the "Company") (NASDAQ:QIPT, TSX:QIPT), a U.S. based home medical equipment provider, focused on end-to-end respiratory care, today announced its fiscal second quarter 2025 financial results and operational highlights. These results pertain to the three and six months ended March 31, 2025, and are reported in United States dollars. Conference Call Quipt will host its Earnings Conference Call on Tuesday, May 13, 2025 at 10:00 a.m. (ET). Interested parties may participate in the call by dialing 1 (833) 752-3722 or 1 (647) 846-8549. A live webcast of the call will be accessible via the investor section of the

    5/12/25 5:00:00 PM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    Quipt Home Medical Corp. to Announce Fiscal Second Quarter 2025 Financial Results on May 12, 2025

    CINCINNATI, April 30, 2025 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (the "Company") (NASDAQ:QIPT) (TSX:QIPT), a U.S. based home medical equipment provider, focused on end-to-end respiratory care, will announce its fiscal Second quarter 2025 financial results on Monday, May 12, 2025, after market close. Gregory Crawford, Chief Executive Officer, and Hardik Mehta, Chief Financial Officer, will host a conference call for the investment community on Tuesday, May 13, 2025, at 10:00 a.m. (ET). The call-in numbers for participants are: Canada/US Toll Free:1 (833) 752 3722International:1 (647) 846 8549   A live webcast of the call will be accessible via the investor section of the Company's w

    4/30/25 7:30:00 AM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    Quipt Home Medical Reports First Quarter Fiscal Year 2025 Financial Results

    CINCINNATI, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. ("Quipt" or the "Company") (NASDAQ:QIPT, TSX:QIPT), a U.S. based home medical equipment provider, focused on end-to-end respiratory care, today announced its first quarter fiscal year 2025 financial results and operational highlights. These results pertain to the three months ended December 31, 2024 and are reported in U.S. Dollars. Conference Call Quipt will host its Earnings Conference Call on Tuesday, February 11, 2025 at 10:00 a.m. (ET). Interested parties may participate in the call by dialing 1 (844) 763-8274 or 1 (647) 484-8814. A live webcast of the call will be accessible via the Company's website at https:/

    2/10/25 5:00:00 PM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    Quipt Home Medical Corp. to Announce Fiscal First Quarter 2025 Financial Results on February 10, 2025

    CINCINNATI, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (the "Company") (NASDAQ:QIPT, TSX:QIPT), a U.S. based home medical equipment provider, focused on end-to-end respiratory care, will announce its fiscal first quarter 2025 financial results on Monday, February 10, 2025, after market close. Gregory Crawford, Chief Executive Officer, and Hardik Mehta, Chief Financial Officer, will host a conference call for the investment community on Tuesday, February 11, 2025, at 10:00 a.m. (ET). The call-in numbers for participants are: Canada/US Toll Free:1 (844) 763 8274International: 1 (647) 484 8814   A live webcast of the call will be accessible via the investor section of the Com

    1/30/25 7:30:00 AM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    Quipt Home Medical Reports Fourth Quarter and Fiscal Year 2024 Financial Results

    Posts Strong Adjusted EBITDA Margin‎1 ‎for Fiscal Year 2024 and Returns to Positive Sequential Growth in Fiscal Q4 2024 CINCINNATI, Dec. 16, 2024 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. ("Quipt" or the "Company") (NASDAQ:QIPT, TSX:QIPT), a U.S. based home medical equipment provider, focused on end-to-end respiratory care, today announced its fourth quarter and fiscal year 2024 financial results and operational highlights. These results pertain to the three months and year ended September 30, 2024 and are reported in U.S. Dollars. The Company no longer qualifies as a "foreign private issuer" as such term is defined in Rule 405 under the U.S. Securities Act of 1933, as ame

    12/16/24 5:00:00 PM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    Quipt Home Medical Corp. to Announce Fiscal Fourth Quarter and Full Year 2024 Financial Results on December 16, 2024

    CINCINNATI, Dec. 04, 2024 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (the "Company") (NASDAQ:QIPT) (TSX:QIPT), a U.S. based home medical equipment provider, focused on end-to-end respiratory care, will announce its fiscal fourth quarter and full year 2024 financial results on Monday, December 16, 2024, after market close. Gregory Crawford, Chief Executive Officer, and Hardik Mehta, Chief Financial Officer, will host a conference call for the investment community on Tuesday, December 17, 2024, at 10:00 a.m. (ET). The call-in numbers for participants are: Canada/US Toll Free:        1 (844) 763 8274International:                      1 (647) 484 8814 A live webcast of the call will be a

    12/4/24 7:30:00 AM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care